Effect of Tris-Hydroxymethyl Aminomethane on intracellular pH depends on the extracellular non-bicarbonate buffering capacity

Translational Research

Volumn 150, Issue 6, 2007, Pages 350-356

  Giunti, Carine ^a   Priouzeau, Fabrice ^a   Allemand, Denis ^a   Levraut, Jacques ^a,b  

^a UNIVERSITÉ CÔTE D'AZUR   (France)

^b University Hospital of Nice University of Nice Sophia Antipolis   (France)

Author keywords

[No Author keywords available]

Indexed keywords

4 (2 HYDROXYETHYL) 1 PIPERAZINEETHANE SULFONIC ACID; BIS CARBOXYETHYL CARBOXY FLUORESCEIN; BUFFER; DYE; METHANE; SULFONIC ACID DERIVATIVE; TRIS HYDROXYMETHYL AMINOMETHANE; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ARTICLE; BLOOD; CELL CULTURE; CELL PH; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CULTURE MEDIUM; FLUORESCENCE; GAS ANALYSIS; HEMATOCRIT; HUMAN; HUMAN CELL; LIVER CELL; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

EID: 36148957105     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2007.05.002     Document Type: Article

References (30)

1. 3 in experimental lactic acidosis in dogs. Am J Physiol 242 (1982) F586-F591
2. Graf H., Leach W., and Arieff A.I. Evidence for a detrimental effect of bicarbonate therapy in hypoxic lactic acidosis. Science 227 (1985) 754-756
3. 3 for the treatment of acidosis. Surgery 102 (1987) 835-839
4. Cooper D.J., and Worthley L.I. Adverse hemodynamic effects of sodium bicarbonate in metabolic acidosis. Intensive Care Med 13 (1987) 425-427
5. Ayus J.C. Effect of bicarbonate administration on cardiac function. Am J Med 87 (1989) 5-6
6. Beech J.S., Iles R.A., and Cohen R.D. Bicarbonate in the treatment of metabolic acidosis: effects on hepatic intracellular ph, gluconeogenesis, and lactate disposal in rats. Metabolism 42 (1993) 341-346
7. Shapiro J. Functional and metabolic responses of isolated hearts to acidosis: effects of sodium bicarbonate and Carbicarb. Am J Physiol (1990) H1835-H1839
8. Shapiro J. Pathogenesis of cardiac dysfunction during metabolic acidosis: therapeutic implications. Kidney Int 51 suppl (1997) S47-S51
9. Shapiro J., Whalen M., and Chan L. Hemodynamic and hepatic pH responses to sodium bicarbonate and carbicarb during systemic acidosis. Magn Reson Med 16 (1990) 403-410
10. Ritter J.M., Doktor H.S., and Benjamin N. Paradoxical effect of bicarbonate on cytoplasmic pH. Lancet 335 (1990) 1243-1246
11. Bjerneroth G., Sammeli, Li Y.C., and Wiklund L. Effects of alkaline buffers on cytoplasmic pH in lymphocytes. Crit Care Med 22 (1994) 1550-1556
12. Goldsmith D.J., Forni L.G., and Hilton P.J. Bicarbonate therapy and intracellular acidosis. Clin Sci 93 (1997) 593-598
13. - depends on blood albumin and hemoglobin concentrations. Intens Care Med 26 (2000) 558-564
14. Nahas G. Use of a organic carbon dioxide buffer in vivo. Science 129 (1959) 782-783
15. Nahas G. The pharmacology of THAM. Pharmacol Rev 14 (1962) 4472
16. Holmdahl M.H., Wiklund L., Wetterberg T., et al. The place of THAM in the management of acidemia in clinical practice. Acta Anesthsiol Scand 44 (2000) 524-527
17. Bleich H., and Schwartz W. Tris buffer (Tham): an appraisal of its physiologic effects and clinical usefulness. N Eng J Med 274 (1966) 782-787
18. Adroguè A.J., and Madias N.E. Management of life-threatening acid-base disorders. N Eng J Med 338 (1998) 26-34
19. Kallet R.H., Jasmer R.M., Luce J.M., Lin L.H., and Marks J.D. The treatment of acidosis in acute lung injury with tris-hydroxymethyl aminomethane (THAM). Am J Respir Crit Care Med 161 (2000) 1149-1153
20. Nahas G.G., Sutin K.M., Fermon C., et al. Guidelines for the treatment of acidemia with THAM. Drugs 55 (1998) 181-224
21. Wetterberg T., and Steen S. Combined use of hypothermia and buffering in the treatment of critical respiratory failure. Acta Anaesthesiol Scand 36 (1992) 490-494
22. Wolf A.L., Levi L., Marmarou A., et al. Effect of THAM upon outcome in severe head injury: a randomized prospective clinical trial. J Neurosurg 78 (1993) 54-59
23. Fermon C. Buffer capacity of THAM. Use in cardioplegia in guidelines for the treatment of acidemia with THAM. Drugs 55 (1998) 194-196
24. Levraut J., Labib Y., Chave S., Payan P., Raucoules-Aime M., and Grimaud D. Effect of sodium bicarbonate on intracellular pH under different buffering conditions. Kidney Int 49 (1996) 1262-1267
25. Levraut J., Giunti C., Ciebiera J.-P., et al. Initial effect of sodium bicarbonate on intracellular pH depends on the extracellular nonbicarbonate buffering capacity. Crit Care Med 29 (2001) 1033-1039
26. Richard B., Fabre G., de Sousa G., Fabre I., Rahmani R., and Cano J.P. Inter-species-variability in mitoxantrone metabolism using primary cultures of hepatocytes isolated from rat, rabbit and humans. Biochem Pharmacol 41 (1991) 255-262
27. de Sousa G., Langouet S., Nicolas F., et al. Increase of cytochrome P-450 lA and glutathione transferase transcripts in cultured hepatocytes from dogs, monkeys, and humans after cryopreservation. Cell Biol Toxicol 2 (1996) 351-358
28. Musgrove E., Rugg C., and Hedley D. Flow cytometric measurement of cytoplasmic pH: a critical evaluation of available fluorochromes. Cytometry 7 (1986) 347-355
29. Bersin R.M., Chattterjee K., and Arieff A.I. Metabolic and hemodynamic consequences of sodium bicarbonate administration in patients with heart disease. Am J Med 87 (1989) 7-14
30. Weber T., Tschernich H., Sitzwohl C., et al. Tromethamine buffer modifies the depressant effect of permissive hypercapnia on myocardial contractility in patients with acute respiratory distress syndrome. Am J Respis Crit Care Med 162 (2000) 1361-1365